Clinical Trial Update: A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

This is an update on an ongoing Phase 2/Phase 3 clinical trial investigating a patient-specific neoantigen vaccine in combination with an immune checkpoint inhi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms

Drugs mentioned

• Immune Checkpoint Blockade (immune checkpoint inhibitor)
• Patient-Specific Neoantigen Vaccine (neoantigen vaccine)

Snippet

Sponsor: Seattle Project Corporation | Conditions: Colorectal Neoplasms | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING